These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26202283)

  • 1. Multifunctional Oligoaminoamides for the Receptor-Specific Delivery of Therapeutic RNA.
    Weber J; Lächelt U; Wagner E
    Methods Mol Biol; 2015; 1324():369-86. PubMed ID: 26202283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-defined oligoaminoamides for the delivery of siRNAs.
    Lee DJ; Wagner E; Lehto T
    Methods Mol Biol; 2015; 1206():15-27. PubMed ID: 25240883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Tackle the Challenge of siRNA Delivery with Sequence-Defined Oligoamino Amides.
    Reinhard S; Wagner E
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27328447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native chemical ligation for conversion of sequence-defined oligomers into targeted pDNA and siRNA carriers.
    Zhang CY; Kos P; Müller K; Schrimpf W; Troiber C; Lächelt U; Scholz C; Lamb DC; Wagner E
    J Control Release; 2014 Apr; 180():42-50. PubMed ID: 24566255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Delivery of Folate-PEG siRNA Lipopolyplexes with Enhanced Intracellular Stability for In Vivo Gene Silencing in Leukemia.
    Lee DJ; Kessel E; Lehto T; Liu X; Yoshinaga N; Padari K; Chen YC; Kempter S; Uchida S; Rädler JO; Pooga M; Sheu MT; Kataoka K; Wagner E
    Bioconjug Chem; 2017 Sep; 28(9):2393-2409. PubMed ID: 28772071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Artificial Amino Acids to Sequence-Defined Targeted Oligoaminoamides.
    Morys S; Wagner E; Lächelt U
    Methods Mol Biol; 2016; 1445():235-58. PubMed ID: 27436323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
    De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
    J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Optimization of Sequence-Defined Oligo(ethanamino)amides for Folate Receptor-Targeted pDNA and siRNA Delivery.
    He D; Müller K; Krhac Levacic A; Kos P; Lächelt U; Wagner E
    Bioconjug Chem; 2016 Mar; 27(3):647-59. PubMed ID: 26726077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial siRNA Polyplexes for Receptor Targeting.
    Lee DJ; Wagner E
    Methods Mol Biol; 2019; 1974():83-98. PubMed ID: 31098997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
    Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
    J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery.
    Dohmen C; Edinger D; Fröhlich T; Schreiner L; Lächelt U; Troiber C; Rädler J; Hadwiger P; Vornlocher HP; Wagner E
    ACS Nano; 2012 Jun; 6(6):5198-208. PubMed ID: 22646997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymers for nucleic acid transfer-an overview.
    Wagner E
    Adv Genet; 2014; 88():231-61. PubMed ID: 25409608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
    Colombo S; Zeng X; Ragelle H; Foged C
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
    Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable polymer-mediated sh/siRNA delivery for cancer studies.
    Jere DJ; Cho CS
    Methods Mol Biol; 2010; 623():243-69. PubMed ID: 20217556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.